Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
Summary
Medtronic reported strong fourth-quarter and full-year fiscal 2026 results, highlighted by its highest annual revenue growth in 10 years. The company posted $36.4 billion in FY26 revenue and raised its quarterly dividend for the 49th straight year. It also pointed to continued momentum in Cardiac Ablation, Surgical, and Diabetes, while noting FDA submissions and clearances across several product areas. Medtronic expects FY27 organic revenue growth of 6.75% to 7.25% and plans to continue using tuck-in M&A and portfolio investment to support growth.
Classifications
industries
HealthTech
applications
Web and Content Management
AskAI Classifications
Labels
Healthcare Software
SaaS
Medical Device Software
Linked Companies
Medtronic plc
$1B+
CathWorks
$1M to $5M